From the New Diagnostic Criteria to COVID-19 Pandemic Passing Through the Placebo Effect. What Have We Learned in the Management of Pediatric Migrane Over the Past 5 Years?

In 2018, the Food and Drug Administration (FDA) approval of anti-calcitonin gene-related peptide (CGRP) therapies for the treatment of migraine represented a milestone for the management of the disease in adults. On the contrary, the novelties in the field of pediatric migraine are inserted in a dif...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Laura Papetti, Samuela Tarantino, Fabiana Ursitti, Romina Moavero, Martina Checchi Proietti, Giorgia Sforza, Gabriele Monte, Michela Ada Noris Ferilli, Martina Balestri, Federico Vigevano, Massimiliano Valeriani
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2022-07-01
Seria:	Frontiers in Neurology
Hasła przedmiotowe:	migraine headache children treatment management diagnosis
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fneur.2022.935803/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!